Literature DB >> 21279150

Hyperlipidemia: time to treat?

M A Mishkel.   

Abstract

This review emphasizes the practical management of hyperlipidemia (HLD), based on five key references published since 1982. It answers seven basic questions: Who should be screened for HLD? How should they be screened? When should they be screened? What should be expected of the laboratory? Why screen for and treat HLD? What should be expected from treatment of HLD? How should HLD be treated? Dietary and drug management are described.

Entities:  

Year:  1985        PMID: 21279150      PMCID: PMC2327313     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  3 in total

1.  Probucol: a weak hypocholesterolemic agent.

Authors:  M A Mishkel; S M Crowther
Journal:  Can Med Assoc J       Date:  1981-07-15       Impact factor: 8.262

2.  Regression of atherosclerosis.

Authors:  A M Gotto
Journal:  Am J Med       Date:  1981-05       Impact factor: 4.965

3.  Regression and progression of early femoral atherosclerosis in treated hyperlipoproteinemic patients.

Authors:  R Barndt; D H Blankenhorn; D W Crawford; S H Brooks
Journal:  Ann Intern Med       Date:  1977-02       Impact factor: 25.391

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.